Physician profile
Joshua Frederick
NPI 1952750549
$1,190.87
in general payments reported to CMS, 2019-2025
15 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.34 · 2022: $22.17 · 2023: $123 · 2024: $578 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $281.15 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $213.97 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.21 | 2024-2025 | Jardiance, Ofev |
| Alexion Pharmaceuticals, INC. | $125.09 | 2024 | Ultomiris |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $104.96 | 2023 | |
| Exact Sciences Corporation | $59.04 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $51.62 | 2019-2024 | Repatha, Otezla |
| Abbott Laboratories | $43.54 | 2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $41.62 | 2025 | Shingrix, Arexvy |
| Lilly USA, LLC | $36.53 | 2019-2025 | Zepbound, Mounjaro |
| Phathom Pharmaceuticals, INC. | $22.37 | 2024 | Voquezna |
| Pfizer INC. | $20.59 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.53 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.52 | 2024 | Xarelto |
| Sun Pharmaceutical Industries INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.